Clinical Trials in New York

Showing 17081-17100 of 22,668 trials

Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis

NCT00572065

This is an open-label, one arm, single institution study. Arsenic trioxide \[TrisenoxTM Injection\], 0.25mg/kg/dose administered intravenously over 2 hours. 20 patients Complete remission, partial remission, clinical improvement, progressive disease, stable disease, relapse (per IWG consensus criteria, 2006) Clinical chemistry, hematology and ECGs will be assessed at least weekly during study treatments. Adverse events will be assessed in accordance with the NCI Common Toxicity Criteria, Version 2 at each study visit.

Myelofibrosis

Weill Medical College of Cornell University21 participantsStarted Feb 2008

New York, New York, United States

TERMINATEDPhase 3< 1 mile

An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.

NCT02089425

This is a randomized, double blind, placebo controlled, parallel group study to assess the efficacy and safety of K-103-IP compared with placebo patch for treatment of mild to moderate acute pain associated with ankle strain or sprain.

Acute Pain From Ankle Sprain or Strain

Kowa Research Institute, Inc.384 participantsStarted Apr 2014

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tempe, Arizona, United States +44 more locations

Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis

An Efficacy and Safety Study for the Treatment of Mild to Moderate Acute Pain Associated With Ankle Strain or Sprain.

Find Trials by Condition in New York

Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

A Novel Method to Determine HIV Incidence Among Youth

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

EPO906 in Carcinoid and Other Neuroendocrine Tumors

C2P Mobilization Intervention (Pilot)

CDC-ATN Linkage Evaluation

Treatment De-Intensification and Residual HIV-1 in Youth

Linkage to Care - Part II

Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes

Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes

Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System

YouScript IMPACT Registry

A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME

Cancer & Chemotherapy Symptom Management Using an Automated Telephone Reporting System

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes